PALO ALTO, Calif., April 19, 2018 /PRNewswire/ -- Varian (NYSE: VAR) today announced it will be showcasing the expanded imagingand treatment capabilities of the Halcyon™ system and the new version of the Velocity™ cancer imaging software, April 20-23 in Barcelona, Spain at ESTRO 37 (European
Additional Varian solutions being demonstrated at ESTRO 37 includes:
Halcyon 2.0 is currently Works in Progress and not available for sale.
In the EU, the ProBeam RapidScan and Iterative CBCT feature, Velocity 4.0 and Mobius software solutions are Works in Progress and currently unavailable for sale.
Varian is hosting an international oncology summit for customers to kick off its ESTRO activities on April 20th at the Palau Congressos Barcelona.
When: ESTRO 37 is April 20-23, 2018. The exhibition is open from 9:30am – 5pm daily.
Where: Booth # 2800, CCIB, Rambla Prim 1-17, Barcelona, Spain
About Varian Varian is a leader in developing and delivering cancer care solutions, and is focused on creating a world without fear of cancer. Headquartered in Palo Alto, California, Varian employs approximately 6,500 people around the world. For more information, visit http://www.varian.com and follow @VarianMedSys on Twitter.
Mark PlungyDirector, Public Relations+1 (650) 424-5630 email@example.com
Investor Relations Contact
J. Michael BruffSenior Vice President, Investor Relations+1 (650) 424-5163 firstname.lastname@example.org
View original content:http://www.prnewswire.com/news-releases/varian-to-demonstrate-advanced-cancer-care-solutions-at-estro-37-300632635.html
Subscribe to our Free Newsletters!
Mastocytosis is a rare condition marked by accumulation of mast cells under the skin and various ...
Lusutrombopag is used to treat abnormally low platelet counts (thrombocytopenia) in adult patients ...
Stereotypic movement disorder (SMD) is a motor disorder, associated with neurodevelopmental ...View All